Evolent Health, Inc. (NYSE: EVH) is making waves within the healthcare sector, specifically in the health information services industry. With a market capitalization of $888.72 million, the company has carved..
The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a focus on providing essential services through its two..
Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a notable entity in the healthcare sector, providing a range of essential services across the United States. Despite current market volatility, HCSG..
Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector specializing in non-opioid pain management, presents an intriguing opportunity for investors seeking exposure to innovative drug manufacturing. With..
Investors with an eye on the healthcare sector may find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing candidate, particularly given the company’s substantial potential upside of over 55%. Operating within the..
Investors with an eye on the healthcare sector may find Opko Health, Inc. (NASDAQ: OPK) an intriguing prospect. With a market capitalization of $1.09 billion, this Miami-based company operates across..
As investors navigate the challenging landscape of healthcare stocks, 10x Genomics, Inc. (NASDAQ: TXG) presents a compelling case for consideration, especially with the potential upside of 31.90% based on current..
Investors with a keen eye on the healthcare sector may want to take a closer look at Indivior PLC (INDV), a prominent player in the specialty and generic drug manufacturing..
Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company specializing in vaccines, presents an intriguing investment opportunity for those looking to navigate the healthcare sector. With a current market capitalization of..
In the ever-evolving landscape of healthcare, Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player with a unique focus on wearable medical devices. As the company continues to..
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Despite recent challenges reflected..
Pulse Biosciences, Inc. (NASDAQ: PLSE), a notable player in the healthcare sector, has carved a niche for itself as a pioneer in the field of bioelectric medicine. With a market..
Investors focusing on the healthcare sector might find Bausch Health Companies Inc. (NYSE: BHC) a compelling opportunity, particularly due to the potential 58.11% upside based on the average target price...
Individual investors seeking opportunities in the biotechnology sector may find Biohaven Ltd. (BHVN) an intriguing prospect. With its focus on cutting-edge therapies in immunology, neuroscience, and oncology, Biohaven’s pipeline is..
Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company at the forefront of addressing unmet patient needs, has caught the attention of investors with its impressive 86.72% potential upside. Specializing in the..
Investors seeking opportunities in the healthcare sector might find PACS Group, Inc. (PACS) an intriguing proposition. Operating within the medical care facilities industry, PACS is renowned for its skilled nursing..
For investors keen on the biotechnology sector, Tarsus Pharmaceuticals, Inc. (TARS) emerges as a notable contender with an attractive growth prospect. As a commercial-stage biopharmaceutical company, Tarsus is committed to..
MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology industry, stands out with a compelling 87.79% potential upside, according to analyst ratings. With a market capitalization hovering around..
Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investor attention with its substantial potential upside. With an average target price of $55.00, analysts suggest a..
Belite Bio, Inc (NASDAQ: BLTE) is catching the attention of investors with its promising advancements in the biotechnology sector, particularly in the field of retinal degenerative eye diseases. With a..
